IMMUNOTHERAPY FOR STAGE III NSCLC INCLUDED IN THE
Subsidy Coverage of
the CCF Medical Assistance
Programme
MEDICAL ASSISTANCE PROGRAMME FOR
Stage III Lung Cancer Patients on
Concurrent Chemotherapy and Radiation Therapy
BRINGING NEW HOPES TO
Cancer Patients and
Their Families
HELPING YOUR IMMUNE SYSTEM
To Fight Cancers
UNDERSTANDING
Lung Cancer
IMPROVING QUALITY OF LIFE
For Cancer Patients
IMMUNOTHERAPY FOR STAGE III NSCLC INCLUDED IN THE
Subsidy Coverage of
the CCF Medical Assistance
Programme
MEDICAL ASSISTANCE PROGRAMME FOR
Stage III Lung Cancer Patients on
Concurrent Chemotherapy and Radiation Therapy
BRINGING NEW HOPES TO
Cancer Patients and
Their Families
HELPING YOUR IMMUNE SYSTEM
To Fight Cancers
UNDERSTANDING
Lung Cancer
IMPROVING QUALITY OF LIFE
For Cancer Patients
More about immunotherapy
Immunotherapy for lung cancer

There have been many exciting advances in the field of lung cancer treatment. Until the mid-2000's, treatment options for lung cancer were mostly limited to surgery, chemotherapy and radiotherapy. Nowadays, patients with lung cancer often have newer treatment options. This section is to help you understand advances in the treatment of lung cancer using immunotherapies that boost your body's immune system to fight cancer.

Immunotherapy for bladder cancer

Bladder cancer was the first indication for which an immunotherapy was granted approval in 1990.33 Since 2016, more immunotherapies have been approved, including several checkpoint inhibitors in both the first and second line settings. This page features information on bladder cancer and immunotherapy for people with bladder cancer.

Resources
Before entering this website,
please answer the following questions:
1. Please choose*:
2. Information you are looking for*: (allow to choose more than one answer)
3. Please fill in your email address to receive the latest information on this website:
(If you have filled in before, you don't need to fill in again)
*must fill in
Subscribe